These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 486317)

  • 21. [Antitumoral activity of various doses of corynebacterium parvum as a function of the age of mice].
    Stiffel C; Chalvet H; Mazurek C
    Ann Inst Pasteur Immunol (1985); 1985; 136D(1):19-27. PubMed ID: 3840664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma.
    Szymaniec S; James K
    Br J Cancer; 1976 Jan; 33(1):36-50. PubMed ID: 1252329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCG as an adjunct to radiotherapy: a mouse model.
    Kennedy JC; Novak T
    Int J Radiat Oncol Biol Phys; 1977; 2(7-8):685-91. PubMed ID: 893172
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Dec; 38(12):4522-6. PubMed ID: 719637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor immunity induced by hybrid murine tumor cells: requirements for optimal immunization.
    McCune CS; O'Donnell RW; Horan PK; Budd HS; Spennacchio JL; Chuang C; Henshaw EC
    J Natl Cancer Inst; 1982 Sep; 69(3):647-52. PubMed ID: 6955557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of Corynebacterium Parvum anti-tumour activity. II. Protective effect in T-cell-deprived mice.
    Mazurek C; Chalvet H; Stiffel C; Biozzi G
    Int J Cancer; 1977 Oct; 20(4):532-4. PubMed ID: 334678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.
    Fisher B; Gunduz N
    J Natl Cancer Inst; 1979 Jun; 62(6):1545-51. PubMed ID: 286125
    [No Abstract]   [Full Text] [Related]  

  • 30. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antimetastatic activity of spleen macrophages and T-lymphocytes in mice with transplantable tumors].
    Arkhipov SA; Iunker VM
    Eksp Onkol; 1990; 12(3):44-7. PubMed ID: 2344823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of silica on the anti-tumour activity of "Corynebacterium parvum" (author's transl)].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1979; 130(6):815-26. PubMed ID: 232975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Corynebacterium parvum treatment of mice with sarcoma growing in normal or irradiated tissue.
    Suit HD; Sedlacek R; Echteler S
    Cancer Res; 1977 Nov; 37(11):4233-4. PubMed ID: 908052
    [No Abstract]   [Full Text] [Related]  

  • 34. Lysozyme levels and macrophage content of tumor tissue in C3H mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum.
    Mendiondo O; Suit H; Fixler H
    Int J Radiat Oncol Biol Phys; 1978; 4(9-10):829-34. PubMed ID: 711553
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas.
    McBride WH; Woodruff MF; Forbes GM; Moore K
    Br J Cancer; 1982 Sep; 46(3):448-51. PubMed ID: 7126431
    [No Abstract]   [Full Text] [Related]  

  • 36. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide--VIII.
    Fisher B; Gebhardt MC; Saffer EA
    Int J Radiat Oncol Biol Phys; 1978; 4(11-12):975-82. PubMed ID: 721660
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
    Mazureka C; Stiffel C; Chalvet H; Biozzi G
    C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
    Fisher B; Wolmark N; Rubin H
    J Natl Cancer Inst; 1976 Jul; 57(1):225-6. PubMed ID: 1003505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corretation between immunosuppression to tumorigenesis. 1. Humoral immunosuppressing factor.
    Hakim AA
    Eur J Cancer (1965); 1978 Nov; 14(11):1249-60. PubMed ID: 738330
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
    Fisher B; Wolmark N; Coyle J
    J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.